Why the study?
Evaluating and managing stable chest pain or chronic coronary syndrome requires understanding the relative impact of coronary atheroma and myocardial ischemia to guide optimal medical therapy alone versus optimal therapy plus revascularization.
Answers are grounded in this paper and cite their sources.
This review highlights the importance of integrating anatomical and physiological assessments to tailor therapy and revascularization decisions in patients with chronic coronary syndrome.
In the evaluation and management of patients with stable chest pain/chronic coronary syndrome, cardiologists need to be able to weigh up the relative merits of managing these patients using either optimal therapy alone or optimal therapy plus revascularization. These decisions rely on an understanding of both the presence and the degree of coronary atheroma and myocardial ischemia, and the impact that these have on patients' symptoms and their prognosis. In this review the authors examine the relative impact of the anatomical and physiological assessment of patients with chronic coronary syndrome and how it can be used to achieve optimal and tailored therapy.
No takes yet. Share an insight, caveat, or question.
Bashar et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: